The European Society of Gynaecological Oncology (ESGO) reveals the latest clinical practice and research developments in Rare Gynaecological Cancers at ESGO 2018, State of the Art Conference, a multidisciplinary congress dedicated to providing the evidence base to diagnose and manage rare gynecological cancers, up to date scientific reviews on biology, biomarkers, preservation of fertility and the latest updates of the GCIG/ESGO guidelines.
The conference program will feature comprehensive state-of-the art summaries on specific rare cancers by world premier Gynaecological Cancers experts, as well as interactive discussions of unanswered questions and the design of future clinical trials.
ESGO 2018 will incorporate oral and poster sessions, bringing the latest research in rare gynaecological cancers to attendees across Europe. Abstracts submissions will be open until May 31, 2018.
Don't miss out on the opportunity to join peers and key opinion leaders in Lyon, France, October 04-06, 2018. Get a head start, visit ESGO 2018 Conference website.